Literature DB >> 24649101

Association of adiponectin +276G/T polymorphism with knee osteoarthritis.

Dong Zhan1, Pongsak Yuktanandana2, Wilai Anomasiri1, Aree Tanavalee2, Sittisak Honsawek3.   

Abstract

Osteoarthritis (OA) is a prevalent, degenerative joint disorder leading to the destruction of articular cartilage, osteophyte formation and subchondral bone sclerosis. Genetic and environmental factors are involved in the development of OA. The role of adiponectin gene polymorphisms in OA has not yet been established. The aim of this study was to investigate the association of adiponectin +276G/T (rs1501299) gene polymorphism with knee OA. Genotype distributions and allelic frequencies of adiponectin gene, +276G/T polymorphism were determined in a total of 200 subjects (100 knee OA patients and 100 healthy controls). Single-nucleotide polymorphism (SNP) of the adiponectin +276G/T gene was genotyped by polymerase chain reaction (PCR)-restriction fragment length polymorphism analysis. The genotype distribution of +276G/T SNP was observed in the Hardy-Weinberg equilibrium for OA patients and controls. No statistically significant difference was identified between the two groups with respect to genotype distributions and allelic frequencies (P>0.05). The T- and G-allele frequencies were indicated as 24.5 and 75.5%, respectively, in OA patients, whereas the frequency was 23-70% in the control group. Findings of this study therefore suggest that the +276G/T SNP was not associated with susceptibility to knee OA.

Entities:  

Keywords:  Thai population; adiponectin; case-control study; knee osteoarthritis; single-nucleotide polymorphism

Year:  2014        PMID: 24649101      PMCID: PMC3917747          DOI: 10.3892/br.2014.228

Source DB:  PubMed          Journal:  Biomed Rep        ISSN: 2049-9434


  24 in total

1.  Radiological assessment of osteo-arthrosis.

Authors:  J H KELLGREN; J S LAWRENCE
Journal:  Ann Rheum Dis       Date:  1957-12       Impact factor: 19.103

2.  Genetic variation in the SMAD3 gene is associated with hip and knee osteoarthritis.

Authors:  Ana M Valdes; Tim D Spector; Agu Tamm; Kalle Kisand; Sally A Doherty; Elaine M Dennison; Massimo Mangino; Ann Tamm; Irina Kerna; Deborah J Hart; Margaret Wheeler; Cyrus Cooper; Rik J Lories; Nigel K Arden; Michael Doherty
Journal:  Arthritis Rheum       Date:  2010-08

3.  Evidence for a protective role for adiponectin in osteoarthritis.

Authors:  Tsu-Hsin Chen; Linda Chen; Ming-Shium Hsieh; Chih-Peng Chang; Der-Tsay Chou; Shu-Huei Tsai
Journal:  Biochim Biophys Acta       Date:  2006-07-01

4.  Association of MMP-3 (-1612 5A/6A) polymorphism with knee osteoarthritis in Thai population.

Authors:  Sittisak Honsawek; Somkiat Malila; Pongsak Yuktanandana; Aree Tanavalee; Benjamad Deepaisarnsakul; Javad Parvizi
Journal:  Rheumatol Int       Date:  2012-03-29       Impact factor: 2.631

Review 5.  The contribution of adipose tissue and adipokines to inflammation in joint diseases.

Authors:  Eric Toussirot; Gérald Streit; Daniel Wendling
Journal:  Curr Med Chem       Date:  2007       Impact factor: 4.530

6.  Adiponectin induces the anti-inflammatory cytokines IL-10 and IL-1RA in human leukocytes.

Authors:  Anna M Wolf; Dominik Wolf; Holger Rumpold; Barbara Enrich; Herbert Tilg
Journal:  Biochem Biophys Res Commun       Date:  2004-10-15       Impact factor: 3.575

7.  A new player in cartilage homeostasis: adiponectin induces nitric oxide synthase type II and pro-inflammatory cytokines in chondrocytes.

Authors:  R Lago; R Gomez; M Otero; F Lago; R Gallego; C Dieguez; J J Gomez-Reino; O Gualillo
Journal:  Osteoarthritis Cartilage       Date:  2008-02-07       Impact factor: 6.576

8.  Adiponectin may contribute to synovitis and joint destruction in rheumatoid arthritis by stimulating vascular endothelial growth factor, matrix metalloproteinase-1, and matrix metalloproteinase-13 expression in fibroblast-like synoviocytes more than proinflammatory mediators.

Authors:  Hyun-Mi Choi; Yeon-Ah Lee; Sang-Hoon Lee; Seung-Jae Hong; Dae-Hyun Hahm; Sang-Yun Choi; Hyung-In Yang; Myung Chul Yoo; Kyoung Soo Kim
Journal:  Arthritis Res Ther       Date:  2009-11-02       Impact factor: 5.156

9.  Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase.

Authors:  T Yamauchi; J Kamon; Y Minokoshi; Y Ito; H Waki; S Uchida; S Yamashita; M Noda; S Kita; K Ueki; K Eto; Y Akanuma; P Froguel; F Foufelle; P Ferre; D Carling; S Kimura; R Nagai; B B Kahn; T Kadowaki
Journal:  Nat Med       Date:  2002-10-07       Impact factor: 53.440

10.  Impaired multimerization of human adiponectin mutants associated with diabetes. Molecular structure and multimer formation of adiponectin.

Authors:  Hironori Waki; Toshimasa Yamauchi; Junji Kamon; Yusuke Ito; Shoko Uchida; Shunbun Kita; Kazuo Hara; Yusuke Hada; Francis Vasseur; Philippe Froguel; Satoshi Kimura; Ryozo Nagai; Takashi Kadowaki
Journal:  J Biol Chem       Date:  2003-07-23       Impact factor: 5.157

View more
  4 in total

1.  Epistasis between ADIPOQ rs1501299 and PON1 rs662 polymorphisms is potentially associated with the development of knee osteoarthritis.

Authors:  Javier Fernández-Torres; Gabriela Angélica Martínez-Nava; Yessica Zamudio-Cuevas; Karina Martínez-Flores; Rolando Espinosa-Morales
Journal:  Mol Biol Rep       Date:  2019-02-08       Impact factor: 2.316

Review 2.  An insight into rheumatology in Thailand.

Authors:  Worawit Louthrenoo
Journal:  Nat Rev Rheumatol       Date:  2014-09-09       Impact factor: 20.543

3.  Obesity, osteoarthritis and genetic risk: The rs182052 polymorphism in the ADIPOQ gene is potentially associated with risk of knee osteoarthritis.

Authors:  L Jiang; X Zhu; J Rong; B Xing; S Wang; A Liu; M Chu; G Huang
Journal:  Bone Joint Res       Date:  2018-08-04       Impact factor: 5.853

4.  Associations between adipokines gene polymorphisms and knee osteoarthritis: a meta-analysis.

Authors:  Yuqing Wang; Fanqiang Meng; Jing Wu; Huizhong Long; Jiatian Li; Ziying Wu; Hongyi He; Haochen Wang; Ning Wang; Dongxing Xie
Journal:  BMC Musculoskelet Disord       Date:  2022-02-22       Impact factor: 2.362

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.